Navigation Links
MIT: Teaching algae to make fuel
Date:5/24/2011

CAMBRIDGE, Mass. -- Many kinds of algae and cyanobacteria, common water-dwelling microorganisms, are capable of using energy from sunlight to split water molecules and release hydrogen, which holds promise as a clean and carbon-free fuel for the future. One reason this approach hasn't yet been harnessed for fuel production is that under ordinary circumstances, hydrogen production takes a back seat to the production of compounds that the organisms use to support their own growth.

But Shuguang Zhang, associate director of MIT's Center for Biomedical Engineering, and postdocs Iftach Yacoby and Sergii Pochekailov, together with colleagues at Tel Aviv University in Israel and the National Renewable Energy Laboratory in Colorado, have found a way to use bioengineered proteins to flip this preference, allowing more hydrogen to be produced.

"The algae are really not interested in producing hydrogen, they want to produce sugar," Yacoby says the sugar is what they need for their own survival, and the hydrogen is just a byproduct. But a multitasking enzyme, introduced into the liquid where the algae are at work, both suppresses the sugar production and redirects the organisms' energies into hydrogen production. The work is described in a paper being published online this week in the Proceedings of the National Academy of Sciences, and was supported in part by a European Molecular Biology Organization postdoctoral fellowship, the Yang Trust Fund and the U.S. Department of Energy's National Renewable Energy Laboratory.

Adding the bioengineered enzyme increases the rate of algal hydrogen production by about 400 percent, Yacoby says. The sugar production is suppressed but not eliminated, he explains, because "if it went to zero, it would kill the organism."

The research demonstrates for the first time how the two processes carried out by algae compete with each other; it also shows how that competition could be modified to favor h
'/>"/>

Contact: Marta Buczek
mbuczek@mit.edu
617-253-2702
Massachusetts Institute of Technology
Source:Eurekalert

Page: 1 2

Related biology news :

1. NSF grant to launch undergrads from Case Western Reserve into math and science teaching
2. New manual presents robust, state-of-the-art proteomics methods for teaching and research
3. Describing soils: Calibration tool for teaching soil rupture resistance
4. Clemson chemists present revolutionary teaching concepts
5. K-State plant pathologists develop online teaching modules used globally
6. UAB professors book promises solution for teaching evolution without conflict
7. Physical education teaching staff play key role in making you like sport
8. American Sociological Association launches first-of-its-kind teaching tool
9. Ethical issues ignored in teaching, research of sustainability
10. Teaching communication and information literacy skills
11. McMaster, NVIDIA establish first CUDA Teaching Centre in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... (Edmonton) Thanks to important discoveries in basic and ... cancer has mobilized into a complex offensive spanning ... of Alberta chemistry lab could help find new ... developed a compound that targets a specific enzyme ... activity in cells from brain tumours. , Chemistry ...
(Date:8/22/2014)... Green tea polyphenols are strong antioxidants and ... protect spinal cord neurons against oxidative stress? ... Affiliated Hospital of Liaoning Medical University, China ... oxidative stress and inhibit neuronal apoptosis, indicating ... in spinal cord neurons under oxidative stress. ...
(Date:8/22/2014)... birds and the bees. But that old expression ... The fertilization process for flowering plants is particularly ... and female reproductive cells. New research from an ... and including Carnegie,s Wolf Frommer, David Ehrhardt, and ... process that guides flowering plant fertilization. It is ...
Breaking Biology News(10 mins):New enzyme targets for selective cancer therapies 2New enzyme targets for selective cancer therapies 3Calcium and reproduction go together 2
... cancer screening tests are proven to reduce colorectal cancer mortality, ... older receive the recommended tests, according to a report in ... Prevention , a journal of the American Association for Cancer ... conducted a National Health Interview Survey and found only 50 ...
... Using an engineered common cold virus, UCLA researchers delivered ... them, using Positron Emission Tomography (PET), to locate the ... the first place prostate cancer goes before invading other ... lymph nodes are very difficult to find using conventional ...
... probably one of the most commonly used diagnostics in ... the throat while the patient says, "Aaaah". But, research ... Journal of Medical Engineering and Informatics looks set ... The technique could circumvent the problem of the failing ...
Cached Biology News:Colorectal cancer screening rates still too low 2UCLA researchers locate and image prostate cancer as it spreads to lymph nodes 2UCLA researchers locate and image prostate cancer as it spreads to lymph nodes 3Sounding out heart problems automatically 2
(Date:8/22/2014)... August 22, 2014 “Our nation's ... is a national disgrace. Furthermore, every governmental and ... the current, deplorable state of unorganized dysfunction shares ... mistakes," to merely serve as a device to ... of colossal failure(s) that have accumulated through the ...
(Date:8/21/2014)... 2014 Deep Research Report ... professional and in-depth research report on the ... Seaweed Fertilizer information, including Seaweed Fertilizer definition, ... well as industry overview. This research covers ... as well as global industry analysis covering ...
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... Brazil and ... The uptake of several newly approved agents, the ... this indication and the launch of emerging biologics ... markets. In particular, the emerging IL-5 inhibitors will ...
(Date:8/21/2014)... August 21, 2014 Pursuit Solutions ... optimization technology and services for Life Sciences sales ... Pharma’s Use of New Commercial Sales Models” by ... Analytics. , The article examines some innovative models ... are being tested in the pharmaceutical market. Robinson ...
Breaking Biology Technology:5 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2
... a carbon lattice with a honeycomb structure, has great ... electronic devices. But applications have been stymied because the ... not function effectively as a semiconductor to amplify or ... sheets into nanoscale ribbons can open up a larger ...
... , ... ... ... ...
... , ... ... ... ...
Cached Biology Technology:New graphene 'nanomesh' could change the future of electronics 2Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 2Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 3Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 4Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 5Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 6Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 7Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 8Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 9Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease 10Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MIT's Technology Review 2Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MIT's Technology Review 3Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MIT's Technology Review 4Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MIT's Technology Review 5Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MIT's Technology Review 6
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
For use with SSP products or any application requiring agarose gel separation • Multiple formats available to meet various throughput needs • Includes replacement parts for each un...
recombination at attR1 and attR2 sites...
...
Biology Products: